TAKARA HOLDINGS INC.

NEWS RELEASE

This page introduces the press release provided to journalists.

2003

2003.02.12

TAKARA BIO will increase capital through third party allocation and
implement a stock option plan (Issuance of stock acquisition rights)

page top

2003.09.22

Success in developing a new method for monitoring insertion sites of introduced genes with high accuracy

2003.09.03

Samsung Seoul Hospital officially announces that Korea's first Phase I clinical study of angiogenesis gene therapy, supported by Takara Bio Inc., has been completed: expected results were obtained and safety has been verified

2003.05.26

Takara Bio Grants VIRxSYS License to Use RetroNectin™ for Gene Transfer Therapy

2003.05.19

Basic Patent Issued in Japan for Isothermal and Chimeric Primer-Initiated Amplification of Nucleic Acids (ICAN) Method

2003.05.14

Establishment of joint venture company for cancer immunotherapy business by Takara Bio Inc. and The Mizumachi Medical Group

2003.02.17

Takara Bio releases New Meat Discrimination Kits Using Fast and Highly
Sensitive Real Time PCR

2003.02.12

Takara Bio is to collaborate with MolMed on gene therapy in Asia

2003.01.30

Takara Bio Will Release FLT3/ITD Mutation Detection Set for Refractory Leukemia

page top